Overview

A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas

Status:
Completed

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

Phase II Study Concomitant High-Dose Radio-Immuno- and Chemotherapy with simultaneous application of Zevalin and BEAM followed by autologous peripheral stem cell transplantation in relapsed and refractory CD 20+ Non-Hodgkin's lymphoma

Phase:

Phase 2

Details

Lead Sponsor:

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Treatments:

Antibodies, Monoclonal